| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/25/2001 | EP1117389A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs |
| 07/25/2001 | EP1117370A1 CONTROLLED RELEASE FROM COPOLYMERS OF ACRYLIC OR METHACRYLIC ACID/L-DOPA, ACRYLIC OR METHACRYLIC ACID/L-$g(a)-METHYL DOPA, ACRYLIC OR METHACRYLIC ACID/CARBIDOPA AND THEIR COMBINATIONS |
| 07/25/2001 | EP1117355A1 Targeted therapy to a biomedical device |
| 07/25/2001 | EP1117296A1 Combination of bisphosphonate and tetracycline |
| 07/25/2001 | EP0889876B1 Meta-substituted phenylene sulphonamide derivatives |
| 07/25/2001 | EP0876366B1 Angiogenesis inhibiting pyridazinamines |
| 07/25/2001 | EP0794955B1 Hindered n-oxide esters of rapamycin and their use as medicaments |
| 07/25/2001 | EP0788487B1 Process for the preparation of tetrazoles |
| 07/25/2001 | EP0772610B9 Dihydrobenzofuranes |
| 07/25/2001 | EP0741709B1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists |
| 07/25/2001 | EP0684944B1 Coupling product obtained from hystamine and an amino acid |
| 07/25/2001 | CN1305493A Novel cyclosporins |
| 07/25/2001 | CN1305487A Benzo (b) thiepine-1, 1-dioxide derivatives, method for production thereof, medicaments containing these compounds and their use |
| 07/25/2001 | CN1305486A Novel compounds derived from alpha-D-xylose, preparation method and therapeutic use |
| 07/25/2001 | CN1305478A Pyrazolopyrimidinone cGMP PDE 5 inhibitors for treatment of sexual dysfunction |
| 07/25/2001 | CN1305477A Azablicyclic 5-HT, receptor ligands |
| 07/25/2001 | CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein |
| 07/25/2001 | CN1305469A Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 07/25/2001 | CN1305465A Aryl alkanoylpyridazines |
| 07/25/2001 | CN1305464A Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 07/25/2001 | CN1305463A Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 07/25/2001 | CN1305458A Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 07/25/2001 | CN1305454A Anthranilic acid derivatives as inhibitors of CGMP phosphodiesterase |
| 07/25/2001 | CN1305371A Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 07/25/2001 | CN1305342A Methods for reducing levels of homocysteine and C-reactive protein |
| 07/25/2001 | CN1305108A Medicine screen model for screening and evaluating activity of thrombocyte and process for preparing reagent and medicine respectively for diagnosing and treating thrombocyte disease |
| 07/25/2001 | CN1304771A Anshen pill-treating cardio-cerebral angiopathy |
| 07/25/2001 | CN1304770A Heart-nourishing Chinese angelica root pill |
| 07/25/2001 | CN1304769A Blood-cleaning pill |
| 07/25/2001 | CN1304748A Medicine for treating pile |
| 07/25/2001 | CN1304724A Composition for preventing and treating osteoporosis and cancer and decreasing blood fat and its application |
| 07/25/2001 | CN1304687A Se-enriched cordyceps militaris tea and its preparing process |
| 07/25/2001 | CN1068879C Dihydrobenzofuranes |
| 07/25/2001 | CN1068790C Medicinal composition containing total saponin extracted from stem and leaves of Americam ginseng |
| 07/25/2001 | CN1068777C Medical use of 5-hydroxymethyl-2-furol |
| 07/24/2001 | US6265612 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect |
| 07/24/2001 | US6265564 Expressed ligand-vascular intercellular signalling molecule |
| 07/24/2001 | US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects |
| 07/24/2001 | US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects |
| 07/24/2001 | US6265543 Polypeptide for the treatment of eye disorders, tumors, cancer, psoriasis, trauma, psychological, burns and ulcers |
| 07/24/2001 | US6265450 Administering astexanthin |
| 07/24/2001 | US6265446 Antiinflammatory agents; autoimmune diseases |
| 07/24/2001 | US6265445 Cardiovascular disorders |
| 07/24/2001 | US6265434 Antiinflammatory agents |
| 07/24/2001 | US6265431 Cycloalkano-indole and -azaindole derivatives |
| 07/24/2001 | US6265429 Administering phosphodiesrterase inhibitor |
| 07/24/2001 | US6265422 Anticancer agents; cardiovascular disorders |
| 07/24/2001 | US6265420 Aftertreatment; sustained release |
| 07/24/2001 | US6265411 Oxindole derivatives |
| 07/24/2001 | US6265399 Alkylation; cyclization |
| 07/24/2001 | US6265383 Hypothalamic inhibitory factor (hif) has a positive inotropic effect in a whole organ preparation, such as an isolated perfused heart. |
| 07/24/2001 | US6265377 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 07/24/2001 | US6264997 Containing proanthocyanidin and flavonide |
| 07/24/2001 | US6264966 Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | US6264938 Administering polydiallylamine and hydroxy-3-methylglutaryl/3-/, coenzyme a reductase |
| 07/24/2001 | CA2331847A1 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 07/24/2001 | CA2240594C 2,7-substituted octahydro-pyrrolo¬1,2-a|pyrazine derivatives |
| 07/24/2001 | CA2193454C Bioadhesive pharmaceutical composition for the controlled release of active ingredients |
| 07/24/2001 | CA2031588C Substituted cyclohexanols and cyclohexylamines as central nervous system agents |
| 07/24/2001 | CA2030162C Benzothiazepines |
| 07/24/2001 | CA2027936C Cyclic anti-aggregatory peptides |
| 07/24/2001 | CA2026540C Water soluble derivatives of glycoside bioflavonoids, processes for their preparation and related pharmaceutical compositions |
| 07/24/2001 | CA2019369C Sulfur-containing fused pyrimidine derivatives, their production and use |
| 07/19/2001 | WO2001051666A1 Methods for diagnosing and treating heart disease |
| 07/19/2001 | WO2001051645A1 Obg3 globular head and uses thereof for decreasing body mass |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051636A2 Secreted proteins |
| 07/19/2001 | WO2001051615A1 Method for increasing survival rate of cells in animal cell culture under hypoxia condition |
| 07/19/2001 | WO2001051614A1 Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition |
| 07/19/2001 | WO2001051613A1 Method for inhibiting apoptosis under ischemic condition |
| 07/19/2001 | WO2001051523A2 Anti-angiogenic proteins and fragments and methods of use thereof |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051493A1 Benzosulfones with calcium antagonist activity |
| 07/19/2001 | WO2001051491A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof |
| 07/19/2001 | WO2001051487A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | WO2001051482A1 Extraction of flavonoids |
| 07/19/2001 | WO2001051473A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 07/19/2001 | WO2001051472A1 New imidazole derivatives |
| 07/19/2001 | WO2001051471A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 07/19/2001 | WO2001051470A1 Phenanthridine-n-oxides |
| 07/19/2001 | WO2001051464A1 Novel vitamin d analogues |
| 07/19/2001 | WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 07/19/2001 | WO2001051125A1 Inhibitors of prenyl-protein transferase |
| 07/19/2001 | WO2001051087A2 Novel treatment for eye disease |
| 07/19/2001 | WO2001051078A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
| 07/19/2001 | WO2001051048A1 Use of epigallocatechin-gallate for inhibiting angiogenesis |
| 07/19/2001 | WO2001051047A1 Use of fumaric acid derivatives for treating mitochondrial diseases |
| 07/19/2001 | WO2001051014A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | WO2001051003A2 Use of lipid conjugates in the treatment of disease |
| 07/19/2001 | WO2001050873A1 Thickened oil compositions of edible oil |
| 07/19/2001 | WO2001050848A2 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | WO2001006261A3 Screening for therapeutic agents being scap antagonists |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005762A3 Biphenyl derivatives, production thereof and use as mtp inhibitors |
| 07/19/2001 | WO2001005418A3 Tissue regenerating agent |
| 07/19/2001 | WO2001005353A3 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2000071716A3 Vascular endothelial growth factor dimers |